ANN ARBOR, Mich., Aug. 9, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it will hold its 2nd quarter 2011 investor conference call on Monday, August 15, 2011, at 2:00pm EDT. James S. Kuo, M.D., M.B.A., Adeona's Chief Executive Officer, will provide an overview of the Company's drug development programs and commercialization efforts of reaZin™ and wellZin™. Julie Caudill, Adeona's Vice President of Finance, will review the Company's financial results for the 2nd quarter ended June 30, 2011. Adeona will be joined by special guest, Ananda S. Prasad, M.D., Ph.D., a Distinguished Professor of Internal Medicine at Wayne State University School of Medicine, an Adeona Scientific Advisory Board member and the Principal Investigator of two separate clinical studies that evaluated a particular zinc lozenge for reducing symptoms of the common cold. Dr. Prasad will share his expertise in utilizing zinc lozenges to combat symptoms of the common cold and will take questions about his research. As previously announced, Adeona has obtained exclusive access to Dr. Prasad's statistically significant clinical data that demonstrates a reduction in the duration and severity of symptoms associated with the common cold when at least 75 mg of zinc acetate per day in lozenge form are administered within 24 hours of the onset of symptoms. Based on the reduction of common cold symptoms shown in these two clinical studies, Adeona intends to commercialize an oral zinc lozenge as a homeopathic over-the-counter (OTC) drug under the brand name wellZin™. Interested parties should call toll free 1-800-860-2442 (U.S.) or 1-866-605-3852 ( Canada), or from outside North America +1 412-858-4600, fifteen minutes before the start of the call to register and identify themselves as registrants of the 'Adeona' Conference Call. Any registered caller on the toll free line may ask to be placed in the queue for the Question & Answer session. The call will be simulcast on the web at http://www.videonewswire.com/event.asp?id=81780. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL ( http://www.videonewswire.com/event.asp?id=81780) for 30 days after the call. About Ananda S. Prasad, M.D., Ph.D. Dr. Prasad recently received the 2010 Mahidol Award in the Field of Public Health for his groundbreaking research. Among his many achievements, he is credited with identifying zinc deficiency as the underlying cause of growth retardation and hypogonadism that has afflicted millions of children in the developing world. Dr. Prasad estimates that over 2 billion people worldwide currently suffer from zinc deficiency. For over five decades, he has been a vocal advocate of zinc supplementation for diseases characterized by zinc deficiency. Dr. Prasad is the 2007 recipient of the American College of Physicians Award for Outstanding Work in Science as Related to Medicine and has over 200 peer-reviewed publications.